Atovaquone: Difference between revisions
From IDWiki
No edit summary |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
| − | == |
+ | == Background == |
* Antiprotozoal medication |
* Antiprotozoal medication |
||
| − | == Indications == |
+ | === Indications === |
| ⚫ | |||
| + | * [[Babesiosis]], in combination with [[azithromycin]] |
||
| + | * [[Pneumocystis jirovecii]] pneumonia prophylaxis or treatment (mild) |
||
| + | == Dosing == |
||
| ⚫ | |||
| − | * PJP prophylaxis |
||
| + | * [[Pneumocystis]] pneumonia (prophylaxis): 1500 mg p.o. once daily |
||
| ⚫ | |||
| + | * [[Pneumocystis]] pneumonia (treatment, mild-to-moderate): 750 mg p.o. twice daily |
||
| + | |||
| ⚫ | |||
Latest revision as of 16:04, 25 June 2024
Background
- Antiprotozoal medication
Indications
- Malaria, in combination with proguanil (atovaquone-proguanil)
- Babesiosis, in combination with azithromycin
- Pneumocystis jirovecii pneumonia prophylaxis or treatment (mild)
Dosing
- Pneumocystis pneumonia (prophylaxis): 1500 mg p.o. once daily
- Pneumocystis pneumonia (treatment, mild-to-moderate): 750 mg p.o. twice daily
